http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2641163-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 |
| filingDate | 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e94ab9680b72e8cff313f5bf0890bb3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0d91af2a10b28865873b2e6e9aec21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe6e9c86cb20a7cd214ed7166a7120b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cde2be8cd5a96b6d81321a53274edd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5755cf27e04c0cee625cd15a35863122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3867d9d586d1a4bbb4e8c90a394084c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6329c439bd9e5bcb120b4dc8f55cffda |
| publicationDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2641163-C1 |
| titleOfInvention | Method for treatment of sustainable paroxismal states and generalized myoclonia in patients with consequences of heavy damage to brain |
| abstract | FIELD: medicine.SUBSTANCE: patients subjected to medical anaesthesia. The trachea is intubated and the patient is transferred to artificial lung ventilation. At that, after trachea intubation and transfer to artificial lung ventilation, medical anaesthesia is performed, including inhalation anaesthesia with Sevoflurane at a dose of 2.0-3.0 vol % MAC 0.8-0.9 for 24-48 hours and additional intravenous infusion of Ketamine in a dose of 1-2 mg/kg-h for 2 hours, starting from the 2nd hour of medical anaesthesia. Artificial lung ventilation is carried out on a semi-closed contour in the "Pressure control" or "Pressure support" mode under the control of capnometry and arterial blood gases analysis.EFFECT: method allows to increase the effectiveness of treatment of paroxysmal and persistent generalized myoclonia in patients with consequences of heavy brain damage due to the lasting effect of seized paroxysms and hyperkinesia after termination of medical anaesthesia with application of Sevoflurane and Ketamine.1 ex |
| priorityDate | 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.